| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 55.43 mm | 55.43 mm | 55.43 mm | 55.43 mm | 55.43 mm | 55.43 mm |
| Cash burn (monthly) | (no burn) | 154.50 k | 11.60 mm | 12.05 mm | 9.44 mm | 9.35 mm |
| Cash used (since last report) | n/a | 785.07 k | 58.93 mm | 61.24 mm | 47.99 mm | 47.49 mm |
| Cash remaining | n/a | 54.65 mm | -3.49 mm | -5.80 mm | 7.44 mm | 7.95 mm |
| Runway (months of cash) | n/a | 353.7 | -0.3 | -0.5 | 0.8 | 0.9 |
| 13F holders | Current |
|---|---|
| Total holders | 72 |
| Opened positions | 12 |
| Closed positions | 6 |
| Increased positions | 22 |
| Reduced positions | 15 |
| 13F shares | Current |
|---|---|
| Total value | 67.75 bn |
| Total shares | 81.44 mm |
| Total puts | 10.20 k |
| Total calls | 8.70 k |
| Total put/call ratio | 1.2 |
| Largest owners | Shares | Value |
|---|---|---|
| BAYRY Bayer | 12.68 mm | $201.04 mm |
| Versant Venture Capital VI | 11.45 mm | $0.00 |
| FUJIFILM Cellular Dynamics | 6.96 mm | $110.31 mm |
| Bain Capital Life Sciences Investors | 5.41 mm | $9.25 bn |
| VR Adviser | 5.39 mm | $9.22 bn |
| Venrock Healthcare Capital Partners III | 5.39 mm | $6.90 mm |
| Bain Capital Life Sciences Opportunities III | 5.32 mm | $19.53 mm |
| Boxer Capital | 3.90 mm | $6.67 bn |
| Casdin Capital | 3.21 mm | $5.49 bn |
| BlackRock | 2.99 mm | $5.11 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Feb 25 | Brent Pfeiffenberger | Common Stock | Sell | Dispose S | No | No | 0.783 | 34,712 | 27.18 k | 1,192,545 |
| 3 Feb 25 | Douglas Carr | Common Stock | Sell | Dispose S | No | No | 0.78 | 351 | 273.78 | 316,796 |
| 3 Feb 25 | Adrienne Farid | Common Stock | Sell | Dispose S | No | No | 0.78 | 1,054 | 822.12 | 134,076 |
| 4 Dec 24 | Brent Pfeiffenberger | Common Stock | Payment of exercise | Dispose F | No | No | 1.44 | 243,447 | 350.56 k | 1,227,257 |
| 4 Nov 24 | Adrienne Farid | Common Stock | Sell | Dispose S | No | No | 1.227 | 1,033 | 1.27 k | 135,130 |
